HAI | Haematology Association of Ireland

Clinical journal for healthcare specialists

NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

Don't have an account? Register

The Haematology Association of Ireland

The Haematology Association of Ireland drives the growth of haematology knowledge and research across the island of Ireland. HAI organizes an annual meeting every October, hosted in various locations around the island. The Association welcomes members who are qualified, working, or studying in any area of haematology.

We take pride in our diverse community of medical, nursing, and scientific members. Our multidisciplinary committee ensures comprehensive representation of all areas of haematology—encompassing both diagnostic and therapeutic research and practice—at our annual meeting and subspecialty events throughout the year.

Clinical News

Haematology

HAI
Advances in obstetric haematology

Haematological complications continue to represent a major source of morbidity and mortality during

By Dr Ellen O'Rourke, Dr Fionnuala Ní Áinle and Dr Barry Kevane - 01st May 2023
Conference

HAI
Study favours immediate progression to stem cell transplant for hard-to-treat AML

People with acute myeloid leukaemia (AML) whose disease relapsed or did not respond to initial chemotherapy...

By Priscilla Lynch - 08th Jan 2023
Conference

HAI
Ibrutinib on track to replace stem cell transplantation as first-line treatment for MCL

In a new trial from the European MCL Network, people with mantle cell lymphoma (MCL) who...

By Priscilla Lynch - 08th Jan 2023
Conference

HAI
Results of study on gene therapy for beta thalassaemia show positive results

In an international study – the largest to date of gene addition therapy for an inherited...

By Priscilla Lynch - 08th Jan 2023
Conference

HAI
Assessing the burden of adverse events in a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukaemia (CLL)

The following study was presented in poster format at the 64th ASH Annual Meeting and Exposition...

By Priscilla Lynch - 08th Jan 2023
Conference

HAI
New studies presented at ASH 2022 challenge the ‘dogma’ of blood cancer care

Research findings presented during the 64th American Society of Haematology (ASH) Annual Meeting...

By Priscilla Lynch - 08th Jan 2023
Conference

HAI
High-dose methotrexate may make post-treatment steroids unnecessary for some children with ALL or LBL – study

The results of a new study presented at the 2022 ASH Annual Meeting answer some questions...

By Priscilla Lynch - 08th Jan 2023
Clinical News

HAI
State-of-the-art treatment in CLL

Attendees at the recent HAI Annual Meeting heard a talk by internationally renowned haematologist...

By Pat Kelly - 16th Dec 2022
Conference

HAI
Spotlight on aplastic anaemia

The Haematology Association of Ireland (HAI) Annual Meeting 2022 spanned two days and featured more...

By Pat Kelly - 25th Nov 2022
Conference

HAI
The US perspective on bleeding disorders and novel therapies

Bleeding disorders. The Haematology Association of Ireland Annual Meeting 2022 also heard from Prof Robert...

By Pat Kelly - 25th Nov 2022
Conference

HAI
Progress and challenges in B-cell lymphoma

The Haematology Association of Ireland Annual Meeting 2022 heard a lecture delivered by Prof John...

By Pat Kelly - 25th Nov 2022
Conference

HAI
Extremely high standard of clinical presentations and speakers

The Haematology Association of Ireland Annual Meeting 2022 hosted a stellar array of national and...

By Pat Kelly - 25th Nov 2022

The Haematology Association of Ireland

Advances in obstetric haematology

Study favours immediate progression to stem cell transplant for hard-to-treat AML

Ibrutinib on track to replace stem cell transplantation as first-line treatment for MCL

Results of study on gene therapy for beta thalassaemia show positive results

Assessing the burden of adverse events in a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukaemia (CLL)

New studies presented at ASH 2022 challenge the ‘dogma’ of blood cancer care

High-dose methotrexate may make post-treatment steroids unnecessary for some children with ALL or LBL – study

State-of-the-art treatment in CLL

Spotlight on aplastic anaemia

The US perspective on bleeding disorders and novel therapies

Progress and challenges in B-cell lymphoma

Extremely high standard of clinical presentations and speakers

Most Read

Alternative system to deal with CervicalCheck claims proposed

Between the lines of adult safeguarding in the HSE

Physician associates: A solution to doctor burnout?

IT gaps and governance review needed for future pandemic control – ISSPHM

The future of neurological research

Download the Free Mindo App

Read the latest Mindo eCopy

The Medical Independent

News

Comment

Clinical

Podcasts

Life

News Team

Societies

Journals

Quick Links